Dr. Phillip Frost
At OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs.

How many shares does Opko Health have?

Opko Health Inc. (US:OPK) has 458 institutional owners and shareholders (aka shareholding pattern) that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 250,094,132 shares.

Will Opko Health stock go up?

Stock Price Forecast The 5 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.50, with a high estimate of 8.50 and a low estimate of 5.00. The median estimate represents a +70.16% increase from the last price of 3.82.

Does opko own Bioreference?

MANY LAB INDUSTRY EXPERTS and Wall Street investors were caught by surprise when, on June 2, they learned that Opko Health Inc., of Miami, Florida, had agreed to pay $1.47 billion in an all-stock deal to acquire Bio-Reference Laboratories Inc., of Elmwood Park, New Jersey.

Is opko shorted?

OPKO Health (NASDAQ:OPK) is a highly shorted stock — 24% of its float is sold short. For instance, 67% of the float of Match Group is sold short. Carvana is also highly shorted, as is Virgin Galactic.

What does opko Health do?

A Diverse Healthcare Company Focused on Improving Patient Lives. At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions.

Is OPK buy or sell?

(OPK) – Zacks….(Delayed Data from NSDQ)

Is opko a buy?

OPKO Health has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

What kind of company is OPKO Health Corporation?

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol “OPK”. OPKO Health is a diversified healthcare company present in more than 30 countries.

Why is OPKO Health ( OPK ) down so much?

Opko Health Will Test the NFL for Coronavirus. The Stock Is Jumping. Why Is OPKO Health (OPK) Down 5.6% Since Last Earnings Report? Is the Options Market Predicting a Spike in OPKO Health (OPK) Stock? OPKO Health (OPK) Down 9.5% Since Last Earnings Report: Can It Rebound? OPKO Health (OPK) to Report Q4 Earnings: What’s in Store?

How is OPKO stock doing year to date?

Opko’s stock is down 3% year-to-date, while the Health Care Select Sector SPDR Fund has dropped 16%. Coronavirus-test availability is ramping up in the U.S. but in a patchwork fashion that still isn’t meeting demand, according to doctors, health-care administrators and state officials.

Who is the chairman and CEO of OPKO?

The Chairman and CEO of OPKO is Dr. Phillip Frost, a billionaire biotech entrepreneur who previously held Chairman positions during the early stages and successful sales of Key Pharmaceuticals, Ivax Corporation, and Teva Pharmaceuticals.